Published in Exp Mol Pathol on October 01, 1974
Measles virus and its associated diseases. Bacteriol Rev (1977) 1.55
Reversible repression and activation of measles virus infection in neural cells. Proc Natl Acad Sci U S A (1982) 1.04
Defective bud formation in human cells chronically infected with subacute sclerosing panencephalitis virus. J Virol (1976) 0.99
Making it to the synapse: measles virus spread in and among neurons. Curr Top Microbiol Immunol (2009) 0.96
Vaccinia virus meningitis in mice after intracerebral inoculation. Infect Immun (1976) 0.85
Identification of a nonproductive, cell-associated form of measles virus by its resistance to inhibition by recombinant human interferon. J Virol (1987) 0.83
Loss of the endothelin signal pathway in C6 rat glioma cells persistently infected with measles virus. Proc Natl Acad Sci U S A (1991) 0.77
Chronic, relapsing myelitis in hamsters associated with experimental measles virus infection. Proc Natl Acad Sci U S A (1980) 0.75
Effect of neonatal thymectomy on experimental subacute sclerosing panencephalitis in adult hamsters. Infect Immun (1975) 0.75
New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol (1983) 26.67
Two distinct subtypes of human respiratory syncytial virus. J Gen Virol (1985) 5.19
Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet (1987) 3.79
Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology (1987) 3.11
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc Natl Acad Sci U S A (1992) 2.98
Presence of haemagglutinin in the envelope of extracellular vaccinia virus particles. J Gen Virol (1976) 2.78
Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J Infect Dis (1975) 2.54
Respiratory syncytial virus envelope glycoprotein (G) has a novel structure. Nucleic Acids Res (1985) 2.37
Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature (1991) 2.28
The structural and functional diversity of Adenovirus capsid components. J Gen Virol (1969) 2.14
Structural polypeptides of measles virus. J Gen Virol (1978) 2.11
Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1973) 2.10
Appearance and persistence of antibodies against different virus components after regular measles infections. Infect Immun (1972) 2.08
Adsorption and penetration of enveloped and naked vaccinia virus particles. J Virol (1978) 2.06
Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections. J Clin Microbiol (1987) 2.06
Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect Immun (1975) 2.01
Monoclonal antibodies against five structural components of measles virus. I. Characterization of antigenic determinants on nine strains of measles virus. Virology (1983) 1.85
Identification of different measles virus-specific antibodies in the serum and cerebrospinal fluid from patients with subacute sclerosing pancencephalitis and multiple sclerosis. Infect Immun (1972) 1.82
Occurrence of respiratory syncytial virus subtypes A and B strains in Sweden. J Med Virol (1986) 1.81
Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm. Virology (1991) 1.77
Hydrocephalus following viral infection: the pathology of aqueductal stenosis developing after experimental mumps virus infection. J Neuropathol Exp Neurol (1968) 1.75
Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunol Lett (1991) 1.73
Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B. J Gen Virol (1987) 1.73
Respiratory syncytial virus fusion glycoprotein: nucleotide sequence of mRNA, identification of cleavage activation site and amino acid sequence of N-terminus of F1 subunit. Nucleic Acids Res (1985) 1.69
Hydrocephalus as a sequela of experimental myxovirus infections. Exp Mol Pathol (1969) 1.68
Diagnosis of rabies by immunofluorescence in trypsin-treated histologic sections. JAMA (1980) 1.67
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses (1987) 1.67
Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis. Scand J Immunol (1976) 1.66
Chromosome damage associated with the measles virus in vitro. Hereditas (1965) 1.60
Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature (1987) 1.59
Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981-1986. J Infect Dis (1988) 1.58
Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus. Proc Natl Acad Sci U S A (1987) 1.55
Morphogenesis of respiratory syncytial virus in a green monkey kidney cell line (Vero). J Virol (1970) 1.53
Structural components of measles virus. Microbios (1972) 1.51
Five measles virus antigens demonstrated by use of mouse hybridoma antibodies in productively infected tissue culture cells. Arch Virol (1982) 1.50
Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J Gen Virol (1988) 1.50
Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis. Infect Immun (1974) 1.48
Isolation of a Streptococcus mutans strain producing a novel bacteriocin. Infect Immun (1984) 1.48
Enhancement of fluorescent antibody staining of viral antigens in formalin-fixed tissues by trypsin digestion. J Infect Dis (1979) 1.46
Structural differences between subtype A and B strains of respiratory syncytial virus. J Gen Virol (1986) 1.45
Measles virus antibodies in multiple sclerosis. Comparison of antibody titers in cerebrospinal fluid and serum. Arch Neurol (1974) 1.44
Paramyxovirus SV5 and multiple sclerosis. Nature (1989) 1.43
A carrier cell line of measles virus in Lu 106 cells. Arch Gesamte Virusforsch (1967) 1.41
Experimental subacute sclerosing panencephalitis in the hamster: correlation of age with chronic inclusion-cell encephalitis. J Infect Dis (1972) 1.41
Immunological relationships between homologous structural polypeptides of measles and canine distemper virus. J Gen Virol (1980) 1.40
Immunologic properties of purified Sendai virus glycoproteins. J Immunol (1977) 1.39
The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (1999) 1.38
The effect of a carbobenzoxy tripeptide on the biological activities of measles virus. Virology (1971) 1.38
The relationship between the soluble antigens and the virion of adenovirus type 3. I. Morphological characteristics. Virology (1966) 1.36
Systemic alpha-interferon therapy of multiple sclerosis. Neurology (1984) 1.35
Persistence of RNA viruses in the central nervous system. Annu Rev Microbiol (1986) 1.33
Serum antibody responses to individual viral polypeptides in human rotavirus infections. J Gen Virol (1987) 1.31
Cerebrospinal fluid and serum immunoglobulins and antibody titers in mumps meningitis and aseptic meningitis of other etiology. Infect Immun (1978) 1.28
Respiratory syncytial virus: heterogeneity of subgroup B strains. J Gen Virol (1988) 1.27
Viral antibodies in multiple sclerosis. Prog Med Virol (1978) 1.27
Immunological and other biological characteristics of pentons of human adenoviruses. J Virol (1969) 1.26
Molecular characterization of epitopes on the measles virus hemagglutinin protein. Virology (1993) 1.26
Characterization of epitopes on the measles virus hemagglutinin. Virology (1986) 1.25
Virus-induced hydrocephalus: development of aqueductal stenosis in hamsters after mumps infection. Science (1967) 1.24
Immunoglobulins and measles antibodies in optic neuritis. N Engl J Med (1973) 1.22
A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization. J Virol (1990) 1.21
Phylogenetic analysis of partial sequences of elongation factor 1alpha identifies major groups of lice (Insecta: Phthiraptera). Mol Phylogenet Evol (2001) 1.20
Neurosyphilis: intrathecal synthesis of oligoclonal antibodies to Treponema pallidum. Ann Neurol (1982) 1.19
Role of N-linked oligosaccharide chains in the processing and antigenicity of measles virus haemagglutinin protein. J Gen Virol (1994) 1.18
Antibodies against three different structural components of measles virus in patients with multiple sclerosis, their siblings and matched controls. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 1.17
Viral and bacterial antibody responses in multiple sclerosis. Ann Neurol (1980) 1.17
Progressive multifocal leukoencephalopathy and cytarabine. Remission with treatment. JAMA (1973) 1.17
The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies. J Gen Virol (1986) 1.16
Separation and characterization of soluble adenovirus type 9 components. J Virol (1967) 1.16
Vaccine protection against HIV-2 infection in cynomolgus monkeys. AIDS Res Hum Retroviruses (1991) 1.16
Antibodies against measles virus polypeptides in different disease conditions. Infect Immun (1981) 1.16
Purification, morphology and antigenic characterization of measles virus envelope components. J Gen Virol (1984) 1.16
Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res (1990) 1.16
Ultrastructure of soluble antigens and the virion of adenovirus type 4. Arch Gesamte Virusforsch (1967) 1.15
Complete nucleotide sequence of the hemagglutinin-neuraminidase (HN) mRNA of mumps virus and comparison of paramyxovirus HN proteins. Virus Res (1989) 1.15
Measles virus matrix protein detected by immune fluorescence with monoclonal antibodies in the brain of patients with subacute sclerosing panencephalitis. J Virol (1985) 1.15
A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients. Mult Scler (2006) 1.15
Selective infections of olfactory and respiratory epithelium by vesicular stomatitis and Sendai viruses. Neuropathol Appl Neurobiol (1987) 1.14
Site-directed ELISA with synthetic peptides representing the HIV transmembrane glycoprotein. J Med Virol (1987) 1.13
Biological significance of structural adenovirus components. Curr Top Microbiol Immunol (1968) 1.12
Influence of N-linked oligosaccharide chains on the processing, cell surface expression and function of the measles virus fusion protein. J Gen Virol (1995) 1.12
The relationship between soluble antigens and the virion of adenovirus type 3. 3. Immunological identification of fiber antigen and isolated vertex capsomer antigen. Virology (1967) 1.12
IgG1 subclass restriction of oligoclonal measles virus-specific IgG antibodies in patients with subacute sclerosing panencephalitis and in a patient with multiple sclerosis. Scand J Immunol (1977) 1.11
Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology (1993) 1.11
Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapy. Ann Neurol (1977) 1.10
The relationship between the soluble antigens and the virion of adenovirus type 3. IV. Immunological complexity of soluble components. Virology (1969) 1.10
United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Multiple Sclerosis Study Group and the MRI Analysis Center. Mult Scler (2001) 1.09
Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies. Immunology (1991) 1.09
Mumps meningitis: specific and non-specific antibody responses in the central nervous system. Acta Neurol Scand (1982) 1.09
Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity. Proc Natl Acad Sci U S A (1991) 1.08
Agarose electrophoresis of cerebrospinal fluid in multiple sclerosis. A simplified method for demonstrating cerebrospinal fluid oligoclonal immunoglobulin bands. Neurology (1977) 1.08
Mouse cytomegalovirus: placental infection. J Infect Dis (1969) 1.07
The clinical and pathological spectrum of brain-stem vascular malformations. Long-term course stimulates multiple sclerosis. Arch Neurol (1980) 1.07
The correlation between the chromosome pulverization effect and other biological activities of measles virus preparations. Exp Cell Res (1966) 1.06
The relationship between the soluble antigens and the virion of adenovirus type 3. II. Identification and characterization of an incomplete hemagglutinin. Virology (1966) 1.06
Isolation of incomplete adenovirus 16 particles containing viral and host cell DNA. Virology (1977) 1.06
Aqueductal stenosis and hydrocephalus after mumps encephalitis. N Engl J Med (1970) 1.06
Measles virus and inactivated canine distemper virus induce incomplete immunity to canine distemper. Arch Virol (1984) 1.05